[1] 刘永贵,田红,沈雪砚,等.新型外用抗真菌药卢立康唑[J].药物评价研究,2014,37(6):576-580.
[2] Koga H,Nanjoh Y,Makimura K,et al.In vitro antifungal activities of luliconazole,a new topical imidazole[J].Med Mycol,2009,47(6):640-647.
[3] Uchida K,Nishiyama Y,Tanaka T,et al.In vitro activity of novel imidazole antifungal agent NND-502 against Malassezia species[J].Int J Antimicrob Agents,2003,21(3):234-238.
[4] Katsuhisa Uchida,Yayoi Nishiyama HY.In vitro antifungal activity of luliconazole (NND-502),a novel imidazole antifungal agent[J].J Infect Chemother,2004,10(4):216-219.
[5] FDA.Luzu Prescribing Information[J].2014:[OL].[2014-2001-11] (2014-2008-02).http://www.accessdata.fda.gov/drugsatfda_docs/label/2013/204153s000lbl.pdf.
[6] 符美华,李岷,李若瑜,等.不同疗程1%卢立康唑乳膏治疗足癣的多中心、随机双盲对照研究[J].中华皮肤科杂志,2014,47(7):453-456.
[7] Watanabe S,Takahashi H,Nishikawa T,et al.A comparative clinical study between 2 weeks of luliconazole 1% cream treatment and 4 weeks of bifonazole 1% cream treatment for tinea pedis[J].Mycoses,2006,49(3):236-241. |